Knowledge of nursing of thrombolytic administration in patients with acute myocardial infarction
DOI:
https://doi.org/10.35381/s.v.v7i1.3593Keywords:
Angina unstable, infarction, myocardial infarction, (Source: DeCS)Abstract
Objective: To determine the knowledge of nursing staff in the care of thrombolytic administration in patients with acute myocardial infarction. Methods: descriptive observational study. Results: 72.5% of the respondents know that the mechanism of action of Alteplase, active inducing conversion of plasminogen to plasmin leading to dissolution of the fibrin clot. Conclusion: It is verified that part of the staff is unaware of the treatment, so training is required to strengthen continuing education and the implementation of tools that favor nursing interventions and actions for patients who need fibrinolytic treatment.
Downloads
References
Zhang Y, Yu X, Jin Q, et al. Advances in targeted therapy for chronic thromboembolic pulmonary hypertension. Heart Fail Rev. 2019;24(6):949-965. https://doi.org10.1007/s10741-019-09798-x
Ikeda N. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Cardiovasc Interv Ther. 2020;35(2):130-141. https://doi.org/10.1007/s12928-019-00637-2
Tanabe N, Sugiura T, Tatsumi K. Recent progress in the diagnosis and management of chronic thromboembolic pulmonary hypertension. Respir Investig. 2013;51(3):134-146. https://doi.org/10.1016/j.resinv.2013.02.005
Teerapuncharoen K, Bag R. Chronic Thromboembolic Pulmonary Hypertension. Lung. 2022;200(3):283-299. https://doi.org/10.1007/s00408-022-00539-w
Dattoli-García Carlos A., Jackson-Pedroza Cynthia N., Gallardo-Grajeda Andrea L., Gopar-Nieto Rodrigo, Araiza-Garygordobil Diego, Arias-Mendoza Alexandra. Infarto agudo de miocardio: revisión sobre factores de riesgo, etiología, hallazgos angiográficos y desenlaces en pacientes jóvenes [Acute myocardial infarction: review of risk factors, etiology, angiographic findings and outcomes in young patients]. Arch. Cardiol. Méx. 2021;91(4):485-492.
Atwood J. Management of Acute Coronary Syndrome. Emerg Med Clin North Am. 2022;40(4):693-706. https://doi.org/10.1016/j.emc.2022.06.008
Smit M, Coetzee AR, Lochner A. The Pathophysiology of Myocardial Ischemia and Perioperative Myocardial Infarction. J Cardiothorac Vasc Anesth. 2020;34(9):2501-2512. https://doi.org/10.1053/j.jvca.2019.10.005
Amatangelo MP, Thomas SB. Priority Nursing Interventions Caring for the Stroke Patient. Crit Care Nurs Clin North Am. 2020;32(1):67-84. https://doi.org/10.1016/j.cnc.2019.11.005
Mosconi MG, Paciaroni M. Treatments in Ischemic Stroke: Current and Future. Eur Neurol. 2022;85(5):349-366. https://doi.org/10.1159/000525822
Qi X, Lin H. Alteplase associated Orolingual angioedema: A case report and literature review. Medicine (Baltimore). 2022;101(52):e32474. https://doi.org/10.1097/MD.0000000000032474
Warach SJ, Dula AN, Milling TJ Jr. Tenecteplase Thrombolysis for Acute Ischemic Stroke. Stroke. 2020;51(11):3440-3451. https://doi.org/10.1161/STROKEAHA.120.029749
Alemseged F, Ng FC, Williams C, et al. Tenecteplase vs Alteplase Before Endovascular Therapy in Basilar Artery Occlusion. Neurology. 2021;96(9):e1272-e1277. https://doi.org/10.1212/WNL.0000000000011520
Muir KW. Should Tenecteplase Replace Alteplase for Acute Thrombolysis?. Stroke. 2021;52(3):1091-1093. https://doi.org/10.1161/STROKEAHA.120.033593
Mao R, Zong N, Hu Y, Chen Y, Xu Y. Neuronal Death Mechanisms and Therapeutic Strategy in Ischemic Stroke. Neurosci Bull. 2022;38(10):1229-1247. https://doi.org/10.1007/s12264-022-00859-0
Nepal G, Kharel S, Kumar Yadav J, et al. Low-dose alteplase for the management of acute ischemic stroke in South Asians: A systematic review on cost, efficacy and safety. J Clin Neurosci. 2022;103:92-99. https://doi.org/10.1016/j.jocn.2022.07.002
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 María Rebeca Curichumbi-Guamán, Neris Marina Ortega-Guevara, María Fernanda Morales-Gomez de la Torre, Ariel Romero-Fernández
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
